Exact Mass: 570.1009512

5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl-5-O-alpha-L-(3,4,5-trihydroxybenzoyl)arabinofuranoside

3-O-7-biluteolin

Skyrinol

C30H18O12

(+)-4-O-methylfukugetin|(+)-4-O-methylmorelloflavone

C31H22O11 (570.1162062)

5,5?,6,6?,7,7?-hexahydroxy-3,3?-bis(3-hydroxyphenyl)-4H,4?H-8,8?-bichromene-4,4?-dione|dapholidin B

5,5?,6,6?,7,7?-hexahydroxy-3,3?-bis(2-hydroxyphenyl)-4H,4?H-8,8?-bichromene-4,4?-dione|dapholidin C

1-O-phloroglucinyl-2-O-galloyl-6-O-cinnamoyl-beta-D-glucoside

apigenin-4-O-beta-glucopyranoside

(2S,3S)-3,5,4,3,5,7,4-heptahydroxyl furano[2,3:7,8]diflavone

5,5?,6,6?,7,7?-hexahydroxy-3,3?-bis(4-hydroxyphenyl)-4H,4?H-8,8?-bichromene-4,4?-dione|dapholidin A

Myricetin hexaacetate

Bisdehydroxanthomegnin

NSC683137

VC-15B

astragalin-6-trans-p-coumalate

IRIGINOL HEXAACEATATE_major

IRIGINOL HEXAACEATATE

Hoveyda-Grubbs Catalyst M721

C27H30Cl2N2ORu (570.077847)

Nickel,[29H,31H-phthalocyaninato(2-)-kN29,kN30,kN31,kN32]-, (SP-4-1)-

C32H16N8Ni (570.0851326)

oxonol 805 blue

C25H22N4O8S2 (570.0879012)

Cefepime hydrochloride

Cefepime Dihydrochloride Monohydrate

C19H28Cl2N6O6S2 (570.0888728)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams A hydrochloride that is the monohydrate of the dihydrochloride salt of cefepime. C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

5-(3,5-dicarboxyphenyl)-[1,1:3,1-terphenyl]-3,3,5,5-tetracarboxylicacid

(S)-2-(6-bromobenzo[d][1,3]dioxol-5-yl)-N-(4-cyanophenyl)-1-(1-cyclohexylethyl)-1H-benzo[d]imidazole-5-carboxamide

C30H27BrN4O3 (570.1266412)

Tris(2,2-bipyridine)ruthenium(2+)

C30H24N6Ru+2 (570.1105744)

GDP-4-amino-3,4,6-trideoxy-alpha-D-threo-hex-3-enopyranose

C16H24N6O13P2 (570.0876554)

[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,6R)-3-hydroxy-5-imino-6-methyloxan-2-yl] hydrogen phosphate

C16H24N6O13P2 (570.0876554)

Cudranian 2

A flavonol 7-O-beta-D-glucoside that is quercetin substituted by a p-hydroxybenzyl group at position 6 and a beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. It is isolated from the root barks of Cudrania tricuspidata and exhibits radical scavenging effects against 1, 1-diphenyl-2-picrylhydrazyl (DPPH) and anti-lipid peroxidation efficacy on human low-density lipoprotein by TBARS assay.

5-galloylquercetin-3-O-alpha-L-arabinofuranoside

A quercetin O-glucoside in which quercetin is attached to a alpha-L-arabinofuranosyl group at position 3 via a glycosidic linkage while the hydroxy group at position 5 is replaced by a galloyl group. Isolated from the young leaves of Calycolpus warscewiczianus, it exhibits activity against a chloroquine-resistant strain of Plasmodium falciparum.

[(2r,3s,4s,5r,6s)-6-({2-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-6-oxopyran-4-yl}oxy)-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

(10r,11r,12s)-12-(4-bromobenzoyl)-6,6,10,11-tetramethyl-4-phenyl-11,12-dihydro-10h-1,5,9-trioxatriphenylen-2-one

C32H27BrO5 (570.1041752)

10,11,15,19,22-pentahydroxy-24-methyl-13,18,20-trioxo-6-oxaheptacyclo[15.10.2.0¹,¹⁹.0³,¹⁶.0⁵,¹⁴.0⁷,¹².0²¹,²⁶]nonacosa-3(16),4,7,9,11,14,21,23,25,28-decaen-27-yl acetate

C31H22O11 (570.1162062)

methyl (1s,17s,19s,27s)-10,15,19,22,27-pentahydroxy-24-methyl-13,18,20-trioxo-6-oxaheptacyclo[15.10.2.0¹,¹⁹.0³,¹⁶.0⁵,¹⁴.0⁷,¹².0²¹,²⁶]nonacosa-3(16),4,7,9,11,14,21,23,25,28-decaene-11-carboxylate

methyl (1s,17s,19s,27s)-10,15,19,22,27-pentahydroxy-24-methyl-13,18,20-trioxo-6-oxaheptacyclo[15.10.2.0¹,¹⁹.0³,¹⁶.0⁵,¹⁴.0⁷,¹².0²¹,²⁶]nonacosa-3(16),4,7,9,11,14,21,23,25,28-decaene-11-carboxylate

C31H22O11 (570.1162062)

(2s,3r,4s,5s)-2-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-4,5-dihydroxyoxan-3-yl 3,4,5-trihydroxybenzoate

n-(2-bromoethyl)-1-{[(1r,4z,8e,10z,12s,15r,17s)-17-[(4r)-2-hydroxy-4,5-dihydro-1,3-thiazol-4-yl]-5,12-dimethyl-3-oxo-2,16-dioxabicyclo[13.3.1]nonadeca-4,8,10-trien-17-yl]oxy}methanimidic acid

C25H35BrN2O6S (570.139907)

8-[6-(5,7-dihydroxy-4-oxochromen-2-yl)-2,3-dihydroxyphenyl]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one

2,2',4,4',5,5'-hexahydroxy-7,7'-bis(hydroxymethyl)-[1,1'-bianthracene]-9,9',10,10'-tetrone